Cystone tablets

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

didymocarpus pedicellata, saxifraga ligulata, rubia cordifolia, cyperus scariosus, achyranthes aspera, onosma bracteatum, vernonia cinerea, mumie purified, lime silicate calx

Available from:

The Himalaya Drug Company

ATC code:

բուսական ծագման դեղ, պարզ ընթացակարգով

INN (International Name):

didymocarpus pedicellata, saxifraga ligulata, rubia cordifolia, cyperus scariosus, achyranthes aspera, onosma bracteatum, vernonia cinerea, mumie purified, lime silicate calx

Dosage:

65mg+ 49mg+ 16mg+ 16mg+ 16mg+ 16mg+ 16mg+ 13mg+ 16mg

Pharmaceutical form:

tablets

Units in package:

(100) in plastic container

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2018-10-30

Summary of Product characteristics

SUMMARY OF THE PRODUCT CHARACTERISTICS
1.
Trade name of the Medicinal product: Cystone (Uncoated tablets)
2.
Composition:
Each 223 mg contains active ingredients:
EXTS.
Shilapushpa
_Didymocarpus pedicellata _
65 mg
Pasanabheda
_Saxifraga ligulata _
49 mg
Manjishtha
_Rubia cordifolia _
16 mg
Nagaramusta
_Cyperus scariosus _
16 mg
Apamarga
_Achyranthes aspera _
16 mg
Gojiha
_Onosma bracteatum _
16 mg
Sahadevi
_Vernonia cinerea _
16 mg
PDRS.
Shilajeet (Purified)
$
_- _
13 mg
Hajrul Yahood bhasma
_Lime silicate calx _
16 mg
$
Non herbal preparation
Which are processed over the steam of extract of the following herbal
materials mixture Vanatulasi
(
_Ocimum _
_basilicum_
),
Kulattha
(
_Dolichos _
_biflorus_
),
Gokshura
(
_Tribulus _
_terrestris_
),
Lajjalu
(
_Mimosa pudica_
), Balam (
_Pavonia odorata_
), Joratoota (
_Equisetum arvense_
) and Shaka seed
(
_Tectona grandis seed_
).
PROCESSED WITH:
Microcrystalline cellulose
18.00 mg
Carmellose sodium
4.00 mg
INACTIVE INGREDIENTS
:
Microcrystalline cellulose
45.00 mg
Crospovidone
3.00 mg
Cabosil M5
3.00 mg
Sodium carboxy methylcellulose
2.00 mg
Magnesium stearate
2.00 mg
3.
Pharmaceutical form: Tablets
4.
Clinical particulars:
4.1
Therapeutic indications:
a.
Urolithiasis:
➢
Oxalate stones
➢
Phosphate stones
➢
Uric acid and urate calculi
➢
Crystalluria
➢
Prevents post-operative recurrence of calculi
➢
Mixed crystals - glycolic acid
b.
As an adjuvant in:
➢
Urinary tract infections
➢
Urinary tract infections during pregnancy
➢
Non-specific urethritis
➢
Cystitis, pyelitis
➢
Burning micturition
➢
Gout and hyperuricemia
c.
Urgency, incontinence of urine in women
d.
Sialolithiasis
4.2
Posology and Method of administration:
IN ADULTS
_In urolithiasis and crystalluria_
:
2 tablets three times daily for 3 to 4 months, followed by 1 tablet
twice daily till the stone passes
out.
_Urinary infections_
: 2 tablets three times daily depending on the severity, until the
infection is
cleared.
_Burning micturition_
: 2 tablets three times daily for 4 days to 2 weeks